查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1863143

全球眼科黏彈性器材市場：洞察、競爭格局及至2032年預測

Ophthalmic Viscoelastic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

眼科黏彈性器材市場摘要

  • 全球眼科黏彈性設備市場預計將從 2024 年的 4.593 億美元成長到 2032 年的 6.8497 億美元，反映出強勁且持續的成長。
  • 全球眼科黏彈性裝置市場在預測期（2025 年至 2032 年）內將以 5.21% 的複合年成長率成長。
  • 眼科黏彈性設備市場的主要促進因素包括眼科疾病盛行率上升、產品設計技術進步、眼部保健意識和可及性提高、糖尿病盛行率上升以及主要市場參與者產品開發活動增加。
  • 眼科黏彈性器材市場的主要企業包括：B. Braun SE、BestMedical、MINZE HEALTH、Santron Medtronic、Potent Medical、Laborie、MEDKONSULT medical technology sro、The Prometheus Group®、HCItalia srl、DeltaMed、MEDICA SPA、AymedIA SEVS. Ltd、Stericom Ltd、Amecath Medical Technologies、Cook 和 Well Lead Medical Co.。
  • 由於白內障和青光眼的高發病率、人口快速老化以及先進眼科手術的日益普及，北美預計將主導整個眼科黏彈性器械市場。該地區擁有完善的醫療基礎設施、技術精湛的眼科醫生以及優惠的醫保報銷政策。此外，市場領導者的存在和持續的產品創新也進一步鞏固了北美在全球市場的主導地位。
  • 在眼科黏彈性器械市場按類型分類的區隔市場中，預計到 2024 年，黏性眼科黏彈性器械類別將佔最大的市場佔有率。

眼科黏彈性器材市場成長要素

  • 眼科疾病發生率上升導致眼科黏彈性製劑需求激增：白內障、青光眼和糖尿病視網膜病變等眼科疾病的日益普遍，推動了眼科黏彈性製劑需求的激增，因為這些產品在確保眼科手術的安全性和精確性方面發揮著關鍵作用。隨著全球病例數量的增加，尤其是在人口老化的情況下，為了滿足不斷成長的眼科手術需求，對黏彈性製劑的需求也顯著增加。
  • 眼科保健意識的提高和醫療服務的普及正在推動眼科黏彈性製劑市場的發展：人們對眼部健康的日益關注以及眼科保健服務的普及，尤其是在發展中地區，正在擴大眼科黏彈性製劑的市場。政府措施、宣傳宣傳活動以及越來越多的眼科專科醫院和手術中心，使得更多患者能夠接受先進的眼科手術，從而促進了黏彈性製劑的應用。
  • 產品設計的技術進步：隨著新一代眼科黏彈性製劑（OVD）的推出，產品設計的技術進步正在推動眼科黏彈性製劑市場的發展。新一代OVD具有更高的黏度、穩定性和安全性。諸如聚集分散配方和增強的生物相容性等創新正在改善手術效果，提高外科醫生的偏好，並促進其在眼科手術中的廣泛應用。

眼科黏彈性器材市場報告區隔

本研究報告全面概​​述了全球眼科黏彈性器材市場，重點闡述了關鍵趨勢、成長促進因素、課題和機會。該報告按類型、應用、最終用戶和地區對市場進行了詳細區隔，並深入分析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態。報告還詳細介紹了行業領導企業的概況和近期產品開發情況，為企業識別市場潛力、制定戰略規劃以及把握快速成長的眼科黏彈劑市場中的新機會提供了重要數據。

眼科黏彈性物質（OVD），也稱為眼科黏彈劑，是一種用於眼科手術的透明凝膠狀物質。 「黏彈性」一詞源自於其雙重特性：既具有液體的黏性，又具有固體或凝膠的彈性。這些物質是現代眼科手術，特別是白內障和人工水晶體（IOL）植入術中不可或缺的工具。這些器械對前房施加壓力，將眼內組織分隔成不同的區域，有助於穩定脆弱的眼部結構，從而加快患者的術後恢復，使手術更加輕鬆安全。

眼科黏彈性製劑市場整體成長主要受眼科疾病盛行率上升和手術需求增加的推動，同時，不斷提升製劑性能和安全性的技術進步也起到了重要作用。人們對眼科保健的認知不斷提高，眼科醫療服務的可及性也隨之擴大了患者群體，而糖尿病患病率的上升進一步加重了需要手術治療的視力相關疾病的負擔。此外，主要廠商加大產品研發力度，推出創新黏彈性製劑解決方案，進一步促進了全球市場成長。

眼科黏彈性物質（OVD）市場正經歷顯著成長，主要促進因素是白內障、青光眼、糖尿病視網膜病變和屈光不正等眼科疾病的日益普遍。根據DelveInsight的一項分析（2024年）顯示，全球有超過22.5億人因近視和遠視而患有視力障礙，這推動了對矯正眼科手術的需求。不斷擴大的全球患者群體正在推動OVD的應用，因為OVD在穩定前房、保護角膜內皮和提高手術精度方面發揮著至關重要的作用。

白內障手術仍然是黏彈劑的主要應用領域。光是在英國，2023年就將進行超過51.6萬例白內障手術（英國政府，2024年5月），凸顯了老齡化社會中手術數量的不斷成長。由於白內障手術是全球最常見的眼科手術，預計對黏彈劑的需求也將隨之成長，尤其是在醫療基礎設施完善、報銷機制健全的已開發市場。

糖尿病視網膜病變（DR）是糖尿病最常見的眼部併發症之一，也是導致糖尿病的重要因素，因為它通常需要手術干預，例如玻璃體切除術合併白內障手術。根據DelveInsight估計（2024年），全球將有超過1億成年人患有DR，其中近2,900萬例為威脅視力的DR（VTDR）。這些手術嚴重依賴黏彈劑（OVD）來維持前房深度並確保組織處理安全，而黏彈劑的應用正在擴大。

除了疾病負擔之外，眼科手術技術的進步也推動了對黏彈劑的需求。飛秒雷射輔助白內障手術、微創青光眼手術（MIGS）以及高階人工水晶體（IOL）的普及，都要求使用高品質的黏彈劑以確保手術的精準性和安全性。此外，兼具分散性和凝聚性的黏彈劑的日益普及，正在改善手術效果並拓寬其臨床應用範圍。

此外，人口結構變化，例如全球人口快速老化、糖尿病盛行率上升以及新興市場先進眼科醫療服務可及性的提高，預計將進一步推動市場擴張。同時，旨在減少可避免失明和增加眼科醫療基礎設施投資的政府利好政策也為市場發展注入了動力。

預計患者人數增加、手術數量增加、糖尿病相關併發症增加以及技術的不斷進步將推動眼科黏彈性設備市場在預測期內顯著成長。

然而，眼科黏彈性物質（OVD）市場面臨許多課題，主要原因是其高成本和複雜的報銷機制，這會阻礙OVD的普及，尤其是在預算緊張的醫療體系中。此外，嚴格的監管障礙和漫長的核准流程也限制新型OVD的研發，減緩了創新步伐。醫療專業人員對OVD的認知不足和缺乏專業培訓也限制了其有效應用，構成了一項重大的營運課題。而且，如果OVD使用或移除不當，始終存在術後併發症的風險，例如眼壓升高。該市場也面臨眾多廠商的激烈競爭，以及替代手術技術可能減少對OVD的需求。這些因素，加上原料價格的波動，共同構成了OVD市場面臨的重大限制和複雜性。

眼科黏彈性器材市場區隔分析

眼科黏彈性器材市場按類型、應用、最終用戶和地區分類

眼科黏彈性器材市場區域分析

北美眼科黏彈性器材市場趨勢

預計北美將在2024年主導全球眼科黏彈性物質（OVD）市場，約佔全球市場佔有率的41%。這一主導主要得益於白內障和青光眼的高發病率，以及人口快速老化，從而推動了眼科手術數量的成長。該地區先進的醫療基礎設施、強大的眼科醫生網路以及完善的醫保報銷體系，進一步促進了高階手術技術的應用，鞏固了其在全球市場的地位。

根據DelveInsight 2024年的分析，光是在美國，就有超過2,550萬人將患上白內障，約970萬人將患上糖尿病視網膜病變（DR），這是導致糖尿病相關視力障礙的主要原因。雖然白內障和視網膜病變通常需要進行手術治療，例如白內障摘除術和玻璃體切除術，但黏彈劑（OVD）對於維持前房穩定、保護角膜內皮以及確保人工水晶體（IOL）的精準植入至關重要。隨著糖尿病和老齡化相關眼科疾病的持續增加，預計北美地區的手術患者數量將顯著成長，從而推動對黏彈劑的持續需求。

技術創新也是推動該地區成長的因素之一。新一代黏彈劑具有最佳化的黏度特性、雙重作用（聚集和分散）以及預填充輸送系統，從而提高了手術效率、安全性和精準度。例如，愛爾康的DUOVISC®黏彈性系統結合了PROVISC®（聚集）和VISCOAT®（分散）兩種技術，可在白內障手術中為外科醫生提供機械支撐和內皮保護。同樣，博士倫的StableVisc™和TotalVisc™系統也反映了雙重作用黏彈劑的發展趨勢，能夠改善組織保護和手術效果。這些創新不僅減少了併發症和手術時間，還拓展了黏彈劑的應用範圍，使其能夠應用於包括青光眼治療和糖尿病眼部併發症在內的更多手術。

此外，北美OVD市場受益於Alcon、博士倫和強生視力等全球領導企業的存在，以及FDA頻繁的核准和產品上市。該地區在飛秒雷射輔助白內障手術、微創青光眼手術（MIGS）和高階人工水晶體植入等先進眼科技術的早期應用方面也處於領先地位，所有這些技術都高度依賴黏彈性物質來實現最佳效果。

預計在預測期內，龐大且不斷成長的患者群體、不斷增加的手術量、強大的醫療保健基礎設施、有利的報銷政策以及持續的產品創新將共同推動北美 OVD 市場實現顯著且持續的成長，從而鞏固其作為全球領導者的地位。

歐洲黏彈性眼科器材市場趨勢

歐洲正引領眼科黏彈性物質（OVD）市場的成長，這主要得益於多種因素的共同作用，包括眼科疾病的高發生率、完善的醫療基礎設施以及先進外科手術的普及。該地區人口老化，加上白內障和視力障礙疾病盛行率的上升，推動了手術中對OVD的需求。此外，歐洲各國在眼科研發領域蓬勃發展，推動了安全性和有效性不斷提高的創新黏彈性產品的問世。政府的各項措施、優惠的醫療政策以及日益增強的眼部健康意識，進一步促進了OVD在醫院和專業眼科中心的應用。市場領導者的存在以及OVD配方技術的持續進步，也鞏固了歐洲作為全球眼科黏彈性物質市場主要貢獻者的地位。

亞太地區眼科黏彈性器材市場趨勢

亞太地區正崛起為眼科黏彈性物質（OVD）市場的重要成長要素，這主要得益於視力障礙患者的快速成長、醫療基礎設施的不斷完善以及先進眼科手術的日益普及。在中國、印度和日本等國家，人口老化和糖尿病發生率的上升導致白內障、青光眼和糖尿病視網膜病變的盛行率不斷攀升。眼科專科醫療服務的普及、政府促進眼部健康的舉措以及醫院和手術中心的擴建，都推動了OVD的應用。此外，患者和醫療專業人員對黏彈性物質益處的認知不斷提高，也促進了其在都市區和半都市區的應用。龐大的未滿足醫療需求、不斷成長的手術量以及不斷擴大的醫療投資，共同推動了亞太地區成為全球OVD市場成長的重要貢獻者。

以下列出了眼科黏彈性器械市場的主要企業，它們總合佔最大的市場佔有率，並引領著行業趨勢：

  • B. Braun SE
  • BestMedical
  • MINZE HEALTH
  • Santron Medtronic
  • Potent Medical
  • Laborie
  • MEDKONSULT medical technology sro
  • The Prometheus Group(R)
  • HCItalia srl
  • DeltaMed
  • MEDICA SPA
  • Aymed Medical Technology
  • EV.SERVICE ITALIA
  • tic Medizintechnik GmbH & Co. KG
  • Creo Medical Ltd.
  • Stericom Ltd.
  • Amecath Medical Technologies
  • Cook
  • Well Lead Medical Co., Ltd.
  • 其他

眼科黏彈性物質（OVD）市場競爭異常激烈，少數幾家大型跨國公司，尤其是愛爾康、強生視力保健、博士倫和卡爾蔡司醫療，佔了大部分市場佔有率。這種高度的市場集中度源於研發、監管核准以及建立產品安全性和有效性良好聲譽所需的大量投資。這些市場領導利用其豐富的產品組合，提供各種類型的OVD（包括凝聚型、分散型和黏彈性OVD），並經常將其與其他手術器械捆綁銷售，以贏得醫院和診所的訂單。然而，儘管這些跨國公司佔主導地位，市場中也存在一些規模較小、更專業的公司，區域性企業，尤其是在亞太地區，正在不斷崛起。這種充滿活力的市場環境鼓勵持續創新，透過專注於開發能夠改善手術效果、便於取出並滿足特定手術需求的下一代OVD，推動市場發展，迫使競爭對手透過技術和品質來脫穎而出。

眼科黏彈性器材市場最新發展

  • 2025年2月，FDA核准了VIA360™手術系統。 VIA360旨在眼科手術（包括小梁切開術）期間輸送可控劑量的黏彈性液體。
  • 2023 年 4 月，博士倫在美國推出了 StableVisc™ 和 TotalVisc™ 黏彈性眼科手術器械，為外科醫生提供先進的雙重作用保護，並在白內障手術中提高安全性。

眼科黏彈性器材市場區隔

  • 暴露的眼科黏彈性裝置類型
  • 黏性眼科黏彈性物質
  • 分散型眼科黏彈性物質
  • 複合眼科黏彈性物質
  • 黏彈性眼科黏彈性
  • 眼科黏彈性裝置應用範圍
  • 白內障手術
  • 青光眼手術
  • 角膜移植
  • 玻璃體視網膜手術
  • 其他
  • 眼科黏彈性器材的終端用戶市場
  • 醫院
  • 眼科診所
  • 其他
  • 黏彈性眼科器械的區域發展趨勢
  • 北美眼科黏彈性器材市場
  • 美國眼科黏彈性器材市場
  • 加拿大眼科黏彈性器材市場
  • 墨西哥眼科黏彈性器材市場
  • 歐洲眼科黏彈性器材市場
  • 英國眼科黏彈性器材市場
  • 德國眼科黏彈性器材市場
  • 法國眼科黏彈性器材市場
  • 義大利眼科黏彈性器材市場
  • 西班牙眼科黏彈性器材市場
  • 其他歐洲眼科黏彈性器材市場
  • 亞太地區眼科黏彈性器材市場
  • 中國眼科黏彈性器材市場
  • 日本眼科黏彈性器材市場
  • 印度眼科黏彈性器材市場
  • 澳洲眼科黏彈性器材市場
  • 韓國眼科黏彈性器材市場
  • 亞太地區其他眼科黏彈性器材市場
  • 世界其他地區眼科黏彈性器材市場
  • 南美洲眼科黏彈性器材市場
  • 中東眼科黏彈性器材市場
  • 非洲眼科黏彈性器材市場

影響分析

人工智慧驅動的創新正日益影響眼科黏彈性物質（OVD）市場，提升手術精準度、安全性和病患療效。先進的人工智慧演算法與眼科成像系統相結合，能夠分析每位患者的眼部解剖結構和狀況，從而為特定手術推薦最合適的OVD類型，例如內聚型、分散型、混合型或黏彈性適應型。在人工智慧輔助或機器人輔助的白內障和前節手術中，人工智慧可以最佳化OVD注射速度、劑量和注射位置等參數，以確保前房穩定並降低併發症風險。此外，人工智慧驅動的預測模型能夠幫助外科醫生預測術後結果，並指導個人化OVD選擇和手術策略。在產品開發方面，人工智慧和機器學習正被用於模擬黏彈性特性和組織相互作用，加速設計具有更高生物相容性、黏度和雙重作用能力的下一代OVD。總而言之，這些人工智慧驅動的創新不僅提高了手術效率和病人安全，而且還擴大了眼科黏彈性裝置在現代眼科護理中的應用和發展。

美國關稅對眼科黏彈性器材市場的影響分析

美國關稅政策對眼科黏彈性物質（OVD）市場構成重大課題，對製造商和醫療服務提供者都有影響。 2025年，美國對大多數進口醫療設備和組件徵收5%的基本關稅，其中包括OVD生產所必需的關鍵原料，例如透明質酸鈉。

如此高的關稅會導致更高的製造成本，而這些成本往往會轉嫁給醫療服務提供者和患者，這可能會影響眼科手術的可負擔性和可及性。眼鏡產業對這類貿易政策表示擔憂，強調視力保健產品的重要性及其對企業（尤其是小型企業和獨立零售商）帶來的經濟負擔。

為應對這些課題，企業正在尋求替代籌資策略，例如供應鏈多元化和擴大國內生產，以減輕關稅的影響。然而，持續進行的貿易談判以及未來潛在的關稅調整所帶來的不確定性，仍然對美國眼科手術（OVD）市場的穩定和成長構成風險。

目錄

第1章 眼科黏彈性器材市場報告概述

  • 調查範圍
  • 市場區隔
  • 市場假設

2. 眼科黏彈性器材市場摘要整理

  • 市場概覽

第3章：眼科黏彈性器材市場關鍵因素分析

  • 市場促進因素
    • 眼科疾病率不斷上升
    • 提高大眾對眼科護理的認知和獲取途徑
    • 科技進步日新月異
    • 主要市場參與企業的產品開發活動增加
  • 市場阻礙與課題
    • 與OVD移除相關的風險
    • 高成本和報銷難題
    • 監管障礙和嚴格的核准流程
  • 市場機遇
    • 新型OVD配方具有改進的性能，包括更高的黏度。

第4章 影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅的影響分析

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

6. 眼科黏彈性器材市場：波特五力分析

第7章 眼科黏彈性器材市場評估

  • 按類型
    • 黏性眼科黏彈劑
    • 可分散眼科黏彈劑
    • 複合眼科黏彈性劑
    • 黏彈性眼科材料
  • 透過使用
    • 白內障手術
    • 青光眼手術
    • 角膜移植
    • 玻璃體視網膜手術
    • 其他
  • 最終用戶
    • 醫院
    • 眼科診所
  • 地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章Start-Ups資金籌措與投資趨勢

10. 眼科黏彈性器材市場中的公司和產品概況

  • B. Braun SE
  • BestMedical
  • MINZE HEALTH
  • Santron
  • Medtronic
  • Potent Medical
  • Laborie
  • MEDKONSULT medical technology sro
  • The Prometheus Group(R)
  • HCItalia srl
  • DeltaMed
  • MEDICA SPA
  • Aymed Medical Technology
  • EV.SERVICE ITALIA
  • tic Medizintechnik GmbH & Co. KG
  • Creo Medical Ltd.
  • Stericom Ltd.
  • Amecath Medical Technologies
  • Cook
  • Well Lead Medical Co., Ltd.

第11章：KOL視角

第12章計劃方法

第13章：關於 DelveInsight

第14章 免責聲明和聯絡我們

Product Code: DIMDCL0134

Ophthalmic Viscoelastic Devices Market Summary

  • The global ophthalmic viscoelastic devices market is expected to increase from USD 459.30 million in 2024 to USD 684.97 million by 2032, reflecting strong and sustained growth.
  • The global ophthalmic viscoelastic devices market is growing at a CAGR of 5.21% during the forecast period from 2025 to 2032.
  • The market of ophthalmic viscoelastic devices is being primarily driven by the rising prevalence of eye disorders, technological advancements in the product designs, rising awareness and access to eye care, an increase in diabetes prevalence, and an increase in product development activities among the key market players.
  • The leading companies operating in the ophthalmic viscoelastic devices market include B. Braun SE, BestMedical, MINZE HEALTH, Santron Medtronic, Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group(R), HCItalia srl, DeltaMed, MEDICA S.P.A., Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd., Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd., and others.
  • North America is expected to dominate the overall Ophthalmic Viscoelastic Devices market due to the high prevalence of cataract and glaucoma cases, a rapidly aging population, and strong adoption of advanced ophthalmic surgical procedures. The region benefits from well-established healthcare infrastructure, availability of skilled ophthalmic surgeons, and favorable reimbursement policies. Additionally, the presence of leading market players and continuous product innovations further strengthens North America's dominant position in the global market.
  • In the type segment of the ophthalmic viscoelastic devices market, the cohesive ophthalmic viscoelastic category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Ophthalmic Viscoelastic Devices Market

  • Rising prevalence of eye disorders leading to a surge in ophthalmic viscoelastic devices: The rising prevalence of eye disorders such as cataracts, glaucoma, and diabetic retinopathy is driving a surge in demand for ophthalmic viscoelastic devices, as these products play a critical role in ensuring safety and precision during eye surgeries. With increasing cases worldwide, especially among the aging population, the need for OVDs is growing significantly to support the rising volume of ophthalmic procedures.
  • Rising awareness and access to eye care are escalating the market of ophthalmic viscoelastic devices: Rising awareness about eye health and expanding access to ophthalmic care, particularly in developing regions, are escalating the market for ophthalmic viscoelastic devices. Government initiatives, awareness campaigns, and improved availability of specialized eye hospitals and surgical centers are driving higher adoption of OVDs by enabling more patients to undergo advanced eye surgeries.
  • Technological advancement in product design: Technological advancements in product design are boosting the ophthalmic viscoelastic devices market by introducing next-generation OVDs with improved viscosity, stability, and safety profiles. Innovations such as combination cohesive-dispersive formulations and enhanced biocompatibility are enabling better surgical outcomes, increasing surgeon preference, and driving wider adoption in ophthalmic procedures.

Ophthalmic Viscoelastic Devices Market Report Segmentation

This ophthalmic viscoelastic devices market report offers a comprehensive overview of the global Ophthalmic Viscoelastic Devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, and Visco-Adaptive Ophthalmic Viscoelastic), Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, and Others), End-User (Hospitals, Ophthalmology Clinics, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing ophthalmic viscoelastic devices market.

Ophthalmic viscoelastic devices (OVDs), also known as ophthalmic viscosurgical devices, are a class of clear, gel-like substances used in eye surgery. The name "viscoelastic" comes from their dual properties: the viscosity of a fluid and the elasticity of a solid or gel. These substances are essential tools in modern eye surgery, particularly in cataract and intraocular lens (IOL) implantation procedures. These devices help secure the fragile eye structures, along with creating pressure in the anterior cavity, compartmentalizing the interior of the eye, and providing patients with faster healing for easier and safer surgery.

The overall market for ophthalmic viscoelastic devices is being collectively boosted by the rising prevalence of eye disorders, which is driving surgical demand, along with continuous technological advancements that enhance device performance and safety. Growing awareness and improved access to eye care are expanding patient reach, while the increasing prevalence of diabetes is further adding to the burden of vision-related disorders requiring surgical treatment. Additionally, intensified product development activities by key players are introducing innovative OVD solutions, strengthening market growth globally.

What are the latest Ophthalmic Viscoelastic Devices Market Dynamics and Trends?

The ophthalmic viscoelastic devices (OVDs) market is witnessing significant growth, primarily driven by the increasing prevalence of eye disorders such as cataracts, glaucoma, diabetic retinopathy, and refractive errors. According to DelveInsight's analysis (2024), over 2.25 billion people worldwide suffer from near or distance vision impairment, creating a robust demand for corrective eye surgeries. Since OVDs play a vital role in stabilizing the anterior chamber, protecting the corneal endothelium, and enhancing surgical precision, the expanding global patient pool directly supports higher adoption of these devices.

Cataract surgery remains the leading application area for OVDs. In England alone, more than 516,000 cataract surgeries were performed in 2023 (UK Government, May 2024), highlighting the increasing surgical volume in aging populations. With cataract surgery being the most frequently performed ophthalmic procedure globally, the demand for OVDs is set to grow in tandem, particularly in developed markets with advanced healthcare infrastructure and supportive reimbursement frameworks.

Diabetic retinopathy (DR) is another major contributor, as it is among the most common diabetes-related eye complications, often requiring surgical interventions such as vitrectomy or combined cataract procedures. DelveInsight's estimates (2024) indicate that more than 100 million adults worldwide were living with DR, with nearly 29 million cases of vision-threatening DR (VTDR). These surgical interventions heavily depend on OVDs to maintain anterior chamber depth and ensure safe tissue handling, further expanding their utilization.

Beyond disease burden, technological advancements in ophthalmic surgery are accelerating OVD demand. The adoption of femtosecond laser-assisted cataract surgery, minimally invasive glaucoma surgeries (MIGS), and premium intraocular lenses (IOLs) necessitates the use of high-quality viscoelastics for precision and safety. Moreover, the increasing availability of combination OVDs (dispersive + cohesive properties) is enhancing surgical outcomes and broadening their clinical applications.

Additionally, demographic shifts such as the rapidly aging global population, rising diabetes prevalence, and improved access to advanced ophthalmic care in emerging markets are expected to further fuel market expansion. Favorable government initiatives aimed at reducing avoidable blindness and growing investments in eye-care infrastructure also add to the momentum.

Taken together, the convergence of a growing patient pool, rising surgical volumes, increasing diabetes-related complications, and ongoing technological advancements is expected to significantly propel the ophthalmic viscoelastic devices market over the forecast period.

However, the ophthalmic viscoelastic devices (OVDs) market faces significant challenges, primarily driven by the high cost and complex reimbursement landscape, which can hinder adoption, particularly in budget-constrained healthcare systems. The development of new OVDs is also constrained by stringent regulatory hurdles and lengthy approval processes, which slow down innovation. A key operational challenge is the lack of awareness and specialized training among healthcare professionals, limiting the effective use of these devices. Furthermore, there is a constant risk of post-operative complications, such as increased intraocular pressure, if the OVDs are not used or removed correctly. The market also contends with intense competition from numerous players, as well as the potential for displacement by alternative surgical techniques that may reduce the need for OVDs. These factors, alongside raw material price volatility, collectively create notable restraints and complexities for the OVD market.

Ophthalmic Viscoelastic Devices Market Segment Analysis

Ophthalmic Viscoelastic Devices Market by Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, and Visco-Adaptive Ophthalmic Viscoelastic), Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, and Others), End-User (Hospitals, Ophthalmology Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Ophthalmic Viscoelastic Devices Market Regional Analysis

North America Ophthalmic Viscoelastic Devices Market Trends

North America is projected to dominate the global ophthalmic viscoelastic devices (OVD) market in 2024, capturing nearly 41% of the total share. This leadership is underpinned by the high prevalence of cataracts and glaucoma, coupled with a rapidly aging population that fuels the rising number of ophthalmic surgical procedures. The region's advanced healthcare infrastructure, strong network of skilled ophthalmic surgeons, and supportive reimbursement frameworks further promote the adoption of premium surgical technologies, cementing its stronghold in the global market.

According to DelveInsight's analysis (2024), in the United States alone, over 25.5 million people were affected by cataracts, while approximately 9.7 million were living with diabetic retinopathy (DR), a leading diabetes-related cause of vision impairment. Both cataracts and DR frequently require surgical interventions such as cataract extraction and vitrectomy, in which OVDs are indispensable for maintaining anterior chamber stability, protecting the corneal endothelium, and ensuring accurate intraocular lens (IOL) implantation. With the continued rise in diabetes prevalence and age-related ocular disorders, the surgical patient pool in North America is set to expand significantly, driving sustained demand for OVDs.

Technological innovation is another key growth accelerator in the region. Next-generation OVDs feature optimized viscosity profiles, dual-action (cohesive-dispersive) properties, and prefilled delivery systems that improve surgical efficiency, safety, and precision. For example, Alcon's DUOVISC(R) Viscoelastic System, which combines PROVISC(R) (cohesive) with VISCOAT(R) (dispersive), provides surgeons with both mechanical support and endothelial protection during cataract procedures. Similarly, Bausch + Lomb's StableVisc(TM) and TotalVisc(TM) systems reflect the ongoing trend toward dual-action OVDs that enhance tissue protection and surgical outcomes. Such innovations not only reduce complications and procedure time but also expand OVD applications to a broader range of surgeries, including glaucoma management and diabetic eye complications.

Additionally, North America's OVD market is strengthened by the presence of leading global players such as Alcon, Bausch + Lomb, and Johnson & Johnson Vision, alongside frequent FDA approvals and product launches that accelerate adoption. The region also leads in the early integration of advanced ophthalmic technologies, including femtosecond laser-assisted cataract surgery, minimally invasive glaucoma surgeries (MIGS), and premium IOL implantation, all of which rely heavily on viscoelastic devices for optimal outcomes.

Taken together, the combination of a large and expanding patient pool, rising surgical volumes, robust healthcare infrastructure, favorable reimbursement, and ongoing product innovation is expected to fuel substantial and sustained growth of the North American OVD market over the forecast period, reinforcing its position as the global leader.

Europe Ophthalmic Viscoelastic Devices Market Trends

Europe is driving the growth of the ophthalmic viscoelastic devices (OVD) market through a combination of factors, including a high prevalence of eye disorders, well-established healthcare infrastructure, and increasing access to advanced surgical procedures. The region has a significant aging population, which contributes to a rising incidence of cataracts and other vision-impairing conditions, thereby increasing the demand for OVDs in surgeries. Additionally, European countries have strong ophthalmic research and development activities, fostering the introduction of innovative viscoelastic products with improved safety and efficacy. Government initiatives, favorable reimbursement policies, and growing awareness about eye health further support the adoption of OVDs across hospitals and specialized eye care centers. The presence of leading market players and continuous technological advancements in OVD formulations also reinforce Europe's position as a key contributor to the overall growth of the global ophthalmic viscoelastic devices market.

Asia-Pacific Ophthalmic Viscoelastic Devices Market Trends

The Asia-Pacific region is emerging as a major growth driver of the ophthalmic viscoelastic devices (OVD) market due to a rapidly increasing patient pool with vision disorders, expanding healthcare infrastructure, and rising adoption of advanced ophthalmic surgeries. Countries such as China, India, and Japan are witnessing a growing prevalence of cataracts, glaucoma, and diabetic retinopathy, driven by aging populations and increasing rates of diabetes. Improved access to specialized eye care, government initiatives promoting eye health, and the expansion of hospitals and surgical centers are facilitating higher OVD utilization. Additionally, growing awareness among patients and healthcare professionals about the benefits of viscoelastic devices is boosting adoption in both urban and semi-urban regions. The combination of high unmet medical needs, increasing surgical volumes, and expanding healthcare investments makes the Asia-Pacific region a significant contributor to the global OVD market growth.

Who are the major players in the ophthalmic viscoelastic devices market?

The following are the leading companies in the ophthalmic viscoelastic devices market. These companies collectively hold the largest market share and dictate industry trends.

  • B. Braun SE
  • BestMedical
  • MINZE HEALTH
  • Santron Medtronic
  • Potent Medical
  • Laborie
  • MEDKONSULT medical technology s.r.o.
  • The Prometheus Group(R)
  • HCItalia srl
  • DeltaMed
  • MEDICA S.P.A
  • Aymed Medical Technology
  • EV.SERVICE ITALIA
  • tic Medizintechnik GmbH & Co. KG
  • Creo Medical Ltd.
  • Stericom Ltd.
  • Amecath Medical Technologies
  • Cook
  • Well Lead Medical Co., Ltd.
  • Others

How is the competitive landscape shaping the ophthalmic viscoelastic devices market?

The competitive landscape of the ophthalmic viscoelastic devices (OVD) market is highly consolidated, with a few major global players, notably Alcon, Johnson & Johnson Vision, Bausch + Lomb, and Carl Zeiss Meditec, holding a significant portion of the market share. This high market concentration is driven by the considerable investment required for research and development, regulatory approval, and building a strong reputation for product safety and efficacy. These market leaders leverage their extensive portfolios to offer a full range of OVD types (cohesive, dispersive, and viscoadaptive), often bundling them with other surgical equipment to secure contracts with hospitals and clinics. However, despite the dominance of these multinational corporations, the market also features several smaller, specialized companies and a growing presence of regional players, especially in the Asia-Pacific region. This dynamic environment encourages continuous innovation, with companies focusing on developing next-generation OVDs that improve surgical outcomes, are easier to remove, and address specific surgical needs, thereby shaping the market's evolution and forcing competitors to differentiate through technology and quality.

Recent Developmental Activities in the Ophthalmic Viscoelastic Devices Market

  • In February 2025, the FDA granted clearance for the VIA360(TM) surgical system, designed to deliver controlled doses of viscoelastic fluid during ophthalmic surgeries, including trabeculotomy procedures.
  • In April 2023, Bausch + Lomb launched StableVisc(TM), a cohesive ophthalmic viscosurgical device, and the TotalVisc(TM) Viscoelastic System in the U.S., offering surgeons advanced dual-action protection and enhanced safety during cataract surgery.

Ophthalmic Viscoelastic Devices Market Segmentation

  • Ophthalmic Viscoelastic Devices Type Exposure
  • Cohesive Ophthalmic Viscoelastic
  • Dispersive Ophthalmic Viscoelastic
  • Combination Ophthalmic Viscoelastic
  • Visco-Adaptive Ophthalmic Viscoelastic
  • Ophthalmic Viscoelastic Devices Application Exposure
  • Cataract Surgery
  • Glaucoma Surgery
  • Corneal Transplantation
  • Vitreoretinal Surgery
  • Others
  • Ophthalmic Viscoelastic Devices End-Users Exposure
  • Hospitals
  • Ophthalmology Clinics
  • Others
  • Ophthalmic Viscoelastic Devices Geography Exposure
  • North America Ophthalmic Viscoelastic Devices Market
  • United States Ophthalmic Viscoelastic Devices Market
  • Canada Ophthalmic Viscoelastic Devices Market
  • Mexico Ophthalmic Viscoelastic Devices Market
  • Europe Ophthalmic Viscoelastic Devices Market
  • United Kingdom Ophthalmic Viscoelastic Devices Market
  • Germany Ophthalmic Viscoelastic Devices Market
  • France Ophthalmic Viscoelastic Devices Market
  • Italy Ophthalmic Viscoelastic Devices Market
  • Spain Ophthalmic Viscoelastic Devices Market
  • Rest of Europe Ophthalmic Viscoelastic Devices Market
  • Asia-Pacific Ophthalmic Viscoelastic Devices Market
  • China Ophthalmic Viscoelastic Devices Market
  • Japan Ophthalmic Viscoelastic Devices Market
  • India Ophthalmic Viscoelastic Devices Market
  • Australia Ophthalmic Viscoelastic Devices Market
  • South Korea Ophthalmic Viscoelastic Devices Market
  • Rest of Asia-Pacific Ophthalmic Viscoelastic Devices Market
  • Rest of the World Ophthalmic Viscoelastic Devices Market
  • South America Ophthalmic Viscoelastic Devices Market
  • Middle East Ophthalmic Viscoelastic Devices Market
  • Africa Ophthalmic Viscoelastic Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are increasingly influencing the ophthalmic viscoelastic devices (OVD) market by enhancing surgical precision, safety, and patient outcomes. Advanced AI algorithms integrated with ophthalmic imaging and diagnostic systems can analyze individual patient anatomy and ocular conditions to recommend the most appropriate type of OVD, whether cohesive, dispersive, combination, or visco-adaptive, for specific procedures. In AI-assisted or robotic-assisted cataract and anterior segment surgeries, AI can optimize parameters such as injection rate, volume, and placement of the OVD, ensuring stable anterior chamber maintenance and reducing the risk of complications. Additionally, AI-driven predictive models help surgeons anticipate post-operative outcomes, guiding the selection of OVDs and surgical strategies tailored to each patient. On the product development side, AI and machine learning are used to simulate viscoelastic properties and tissue interactions, accelerating the design of next-generation OVDs with improved biocompatibility, viscosity, and dual-action performance. Collectively, these AI-powered innovations are not only improving surgical efficiency and patient safety but also expanding the adoption and evolution of ophthalmic viscoelastic devices in modern ophthalmology.

U.S. Tariff Impact Analysis on Ophthalmic Viscoelastic Devices Market:

The U.S. tariff landscape has introduced significant challenges to the ophthalmic viscoelastic devices (OVD) market, impacting both manufacturers and healthcare providers. In 2025, the U.S. imposed a universal 5% baseline tariff on most imported medical devices and components, including critical raw materials like sodium hyaluronate, essential for OVD production.

These elevated tariffs have led to increased production costs, which are often passed on to healthcare providers and patients, potentially affecting the affordability and accessibility of eye surgeries. The optical industry has expressed concerns over these trade policies, highlighting the essential nature of vision care products and the financial strain on businesses, particularly smaller enterprises and independent retailers.

In response to these challenges, companies are exploring alternative sourcing strategies, such as diversifying supply chains and increasing domestic production, to mitigate the impact of tariffs. However, the uncertainty surrounding ongoing trade negotiations and potential future tariff adjustments continues to pose risks to the stability and growth of the OVD market in the U.S.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the ophthalmic viscoelastic devices market report study

  • Market size analysis for the current ophthalmic viscoelastic devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the ophthalmic viscoelastic devices market.
  • Various opportunities available for the other competitors in the ophthalmic viscoelastic devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current ophthalmic viscoelastic devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the ophthalmic viscoelastic devices market growth in the future?

Frequently Asked Questions for the Ophthalmic Viscoelastic Devices Market

1. What is the growth rate of the ophthalmic viscoelastic devices market?

  • The ophthalmic viscoelastic devices market is estimated to grow at a CAGR of 5.21% during the forecast period from 2025 to 2032.

2. What is the market for ophthalmic viscoelastic devices?

  • The ophthalmic viscoelastic devices market was valued at USD 459.30 million in 2024, and is expected to reach USD 684.97 million by 2032.

3. Which region has the highest share in the ophthalmic viscoelastic devices market?

  • North America is expected to dominate the overall ophthalmic viscoelastic devices market due to the high prevalence of cataract and glaucoma cases, a rapidly aging population, and strong adoption of advanced ophthalmic surgical procedures. The region benefits from well-established healthcare infrastructure, availability of skilled ophthalmic surgeons, and favorable reimbursement policies. Additionally, the presence of leading market players and continuous product innovations further strengthens North America's dominant position in the global market.

4. What are the drivers for the ophthalmic viscoelastic devices market?

  • The overall market for ophthalmic viscoelastic devices is being collectively boosted by the rising prevalence of eye disorders, which is driving surgical demand, along with continuous technological advancements that enhance device performance and safety. Growing awareness and improved access to eye care are expanding patient reach, while the increasing prevalence of diabetes is further adding to the burden of vision-related disorders requiring surgical treatment. Additionally, intensified product development activities by key players are introducing innovative OVD solutions, strengthening market growth globally.

5. Who are the key players operating in the ophthalmic viscoelastic devices market?

  • Some of the key market players operating in the ophthalmic viscoelastic devices market include B. Braun SE, BestMedical, MINZE HEALTH, Santron, Medtronic, Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group(R), HCItalia srl, DeltaMed, MEDICA S.P.A., Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd., Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd., and others.

Table of Contents

1. Ophthalmic Viscoelastic Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Ophthalmic Viscoelastic Devices Market Executive Summary

  • 2.1 Market at Glance

3. Ophthalmic Viscoelastic Devices Market Key Factors Analysis

  • 3.1 Ophthalmic Viscoelastic Devices Market Drivers
    • 3.1.1 Rising prevalence of eye disorders
    • 3.1.2 Rising awareness and access to eye care
    • 3.1.3 Increase in technological advancement
    • 3.1.4 Increase in product development activities among the key market players
  • 3.2 Ophthalmic Viscoelastic Devices Market Restraints and Challenges
    • 3.2.1 Risk associated with OVD removal
    • 3.2.2 High Cost and Reimbursement Challenges
    • 3.2.3 Regulatory Hurdles and Stringent Approval Processes
  • 3.3 Ophthalmic Viscoelastic Devices Market Opportunity
    • 3.3.1 Formulations of new OVDs with improved properties, such as enhanced viscosity

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Ophthalmic Viscoelastic Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Ophthalmic Viscoelastic Devices Market Assessment

  • 7.1 By Type
    • 7.1.1 Cohesive Ophthalmic Viscoelastic
    • 7.1.2 Dispersive Ophthalmic Viscoelastic
    • 7.1.3 Combination Ophthalmic Viscoelastic
    • 7.1.4 Visco-Adaptive Ophthalmic Viscoelastic
  • 7.2 By Application
    • 7.2.1 Cataract Surgery
    • 7.2.2 Glaucoma Surgery
    • 7.2.3 Corneal Transplantation
    • 7.2.4 Vitreoretinal Surgery
    • 7.2.5 Others
  • 7.3 By End-Users
    • 7.3.1 Hospitals
    • 7.3.2 Ophthalmology Clinics
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.1.2 Canada Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.1.3 Mexico Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.2 Europe
      • 7.4.2.1 France Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.2.2 Germany Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.2.3 United Kingdom Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.2.4 Italy Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.2.5 Spain Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.2.6 Rest of Europe Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.3.2 Japan Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.3.3 India Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.3.4 Australia Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.3.5 South Korea Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.3.6 Rest of Asia-Pacific Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.4.2 Africa Ophthalmic Viscoelastic Devices Market Size in USD million (2022-2032)
      • 7.4.4.3 South America Ophthalmic Viscoelastic Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Ophthalmic Viscoelastic Devices Market Company and Product Profiles

  • 10.1 B. Braun SE
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 BestMedical
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 MINZE HEALTH
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Santron
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Medtronic
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Potent Medical
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Laborie
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 MEDKONSULT medical technology s.r.o.
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 The Prometheus Group(R)
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 HCItalia srl
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 DeltaMed
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 MEDICA S.P.A
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Aymed Medical Technology
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 EV.SERVICE ITALIA
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 tic Medizintechnik GmbH & Co. KG
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Creo Medical Ltd.
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Stericom Ltd.
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Amecath Medical Technologies
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Cook
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Well Lead Medical Co., Ltd.
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Ophthalmic Viscoelastic Devices Market in Global (2022-2032)
  • Table 2: Ophthalmic Viscoelastic Devices Market in Global by Type (2022-2032)
  • Table 3: Ophthalmic Viscoelastic Devices Market in Global by End-User (2022-2032)
  • Table 4: Ophthalmic Viscoelastic Devices Market in Global by Geography (2022-2032)
  • Table 5: Ophthalmic Viscoelastic Devices Market in North America (2022-2032)
  • Table 6: Ophthalmic Viscoelastic Devices Market in the United States (2022-2032)
  • Table 7: Ophthalmic Viscoelastic Devices Market in Canada (2022-2032)
  • Table 8: Ophthalmic Viscoelastic Devices Market in Mexico (2022-2032)
  • Table 9: Ophthalmic Viscoelastic Devices Market in Europe (2022-2032)
  • Table 10: Ophthalmic Viscoelastic Devices Market in France (2022-2032)
  • Table 11: Ophthalmic Viscoelastic Devices Market in Germany (2022-2032)
  • Table 12: Ophthalmic Viscoelastic Devices Market in United Kingdom (2022-2032)
  • Table 13: Ophthalmic Viscoelastic Devices Market in Italy (2022-2032)
  • Table 14: Ophthalmic Viscoelastic Devices Market in Spain (2022-2032)
  • Table 15: Ophthalmic Viscoelastic Devices Market in the Rest of Europe (2022-2032)
  • Table 16: Ophthalmic Viscoelastic Devices Market in Asia-Pacific (2022-2032)
  • Table 17: Ophthalmic Viscoelastic Devices Market in China (2022-2032)
  • Table 18: Ophthalmic Viscoelastic Devices Market in Japan (2022-2032)
  • Table 19: Ophthalmic Viscoelastic Devices Market in India (2022-2032)
  • Table 20: Ophthalmic Viscoelastic Devices Market in Australia (2022-2032)
  • Table 21: Ophthalmic Viscoelastic Devices Market in South Korea (2022-2032)
  • Table 22: Ophthalmic Viscoelastic Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 23: Ophthalmic Viscoelastic Devices Market in the Rest of the World (2022-2032)
  • Table 24: Ophthalmic Viscoelastic Devices Market in the Middle East (2022-2032)
  • Table 25: Ophthalmic Viscoelastic Devices Market in Africa (2022-2032)
  • Table 26: Ophthalmic Viscoelastic Devices Market in South America (2022-2032)
  • Table 27: Competitive Landscape
  • Table 28: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Ophthalmic Viscoelastic Devices Market Drivers
  • Figure 2: Ophthalmic Viscoelastic Devices Market Restraints
  • Figure 3: Ophthalmic Viscoelastic Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in Ophthalmic Viscoelastic Devices Market
  • Figure 5: US Tariff Impact on Ophthalmic Viscoelastic Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Ophthalmic Viscoelastic Devices Market in Global (2022-2032)
  • Figure 10: Ophthalmic Viscoelastic Devices Market in Global by Type (2022-2032)
  • Figure 11: Ophthalmic Viscoelastic Devices Market in Global by End-User (2022-2032)
  • Figure 12: Ophthalmic Viscoelastic Devices Market in Global by Geography (2022-2032)
  • Figure 13: Ophthalmic Viscoelastic Devices Market in North America (2022-2032)
  • Figure 14: Ophthalmic Viscoelastic Devices Market in the United States (2022-2032)
  • Figure 15: Ophthalmic Viscoelastic Devices Market in Canada (2022-2032)
  • Figure 16: Ophthalmic Viscoelastic Devices Market in Mexico (2022-2032)
  • Figure 17: Ophthalmic Viscoelastic Devices Market in Europe (2022-2032)
  • Figure 18: Ophthalmic Viscoelastic Devices Market in France (2022-2032)
  • Figure 19: Ophthalmic Viscoelastic Devices Market in Germany (2022-2032)
  • Figure 20: Ophthalmic Viscoelastic Devices Market in United Kingdom (2022-2032)
  • Figure 21: Ophthalmic Viscoelastic Devices Market in Italy (2022-2032)
  • Figure 22: Ophthalmic Viscoelastic Devices Market in Spain (2022-2032)
  • Figure 23: Ophthalmic Viscoelastic Devices Market in the Rest of Europe (2022-2032)
  • Figure 24: Ophthalmic Viscoelastic Devices Market in Asia-Pacific (2022-2032)
  • Figure 25: Ophthalmic Viscoelastic Devices Market in China (2022-2032)
  • Figure 26: Ophthalmic Viscoelastic Devices Market in Japan (2022-2032)
  • Figure 27: Ophthalmic Viscoelastic Devices Market in India (2022-2032)
  • Figure 28: Ophthalmic Viscoelastic Devices Market in Australia (2022-2032)
  • Figure 29: Ophthalmic Viscoelastic Devices Market in South Korea (2022-2032)
  • Figure 30: Ophthalmic Viscoelastic Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 31: Ophthalmic Viscoelastic Devices Market in the Rest of the World (2022-2032)
  • Figure 32: Ophthalmic Viscoelastic Devices Market in the Middle East (2022-2032)
  • Figure 33: Ophthalmic Viscoelastic Devices Market in Africa (2022-2032)
  • Figure 34: Ophthalmic Viscoelastic Devices Market in South America (2022-2032)
  • Figure 35: Competitive Landscape
  • Figure 36: Startup Funding & Investment Trends